Apolipoprotein A-V is a Potent Modulator of HDL and VLDL Components in Preadolescent Children

被引:5
作者
Abe, Yuriko [1 ]
Okada, Tomoo [1 ]
Kuromori, Yuki [1 ]
Hara, Mitsuhiko [2 ]
Saito, Emiko [2 ]
Iwata, Fujihiko [1 ]
Harada, Kensuke [1 ]
Mugishima, Hideo [1 ]
机构
[1] Nihon Univ, Sch Med, Dept Pediat & Child Hlth, Itabashi Ku, Tokyo 1738610, Japan
[2] Tokyo Metropolitan Hiroo Gen Hosp, Dept Pediat, Tokyo, Japan
关键词
Apolipoprotein A-V; Large HDL particles; Hypertriglyceridemia; VLDL-TG; TRIGLYCERIDE-RICH LIPOPROTEINS; METABOLIC SYNDROME; TRANSGENIC MICE; APOA5; ATHEROSCLEROSIS; ASSOCIATION; HYDROLYSIS; DEFICIENCY; SERUM; RISK;
D O I
10.5551/jat.E356
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Aim: Mice lacking apolipoprotein A-V (apoA-V) displayed an increase in serum triglyceride (TG) levels; however, the correlation of apoA-V levels with TG levels in humans is controversial, and the exact mechanism by which apoA-V affects TG levels is unclear. The aim of the present study was to clarify the impact of apoA-V on the lipoprotein subclass profile in preadolescent children, which has not been studied. Method: The study subjects were 178 (89 male, 89 female) 4th grade elementary school children (mean +/- SD: 9.5 +/- 0.5 years old). ApoA-V levels were determined by an enzyme-linked immunosorbent assay, and the lipid component of each lipoprotein fraction and their particle sizes were measured by HPLC. Results: Levels of apoA-V showed no gender difference in preadolescent children, and were not affected by anthropometric variables. ApoA-V had a negative association with serum TG levels and TG levels in each lipoprotein fraction, and a positive association with HDL-C. In particular, apoA-V appears to contribute to the increase in cholesterol levels in the larger HDL fraction. Conclusions: It was suggested that apoA-V is a potent modulator of HDL and VLDL components in preadolescent children.
引用
收藏
页码:121 / 126
页数:6
相关论文
共 29 条
[1]   Apolipoprotein composition of HDL in cholesteryl ester transfer protein deficiency [J].
Asztalos, BF ;
Horvath, KV ;
Kajinami, K ;
Nartsupha, C ;
Cox, CE ;
Batista, M ;
Schaefer, EJ ;
Inazu, A ;
Mabuchi, H .
JOURNAL OF LIPID RESEARCH, 2004, 45 (03) :448-455
[2]   Altered apolipoprotein A-V expression during the acute phase response is independent of plasma triglyceride levels in mice and humans [J].
Becker, S ;
Schomburg, L ;
Renko, K ;
Tölle, M ;
van der Giet, M ;
Tietge, UJF .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2006, 339 (03) :833-839
[3]   High plasma HDL concentrations associated with enhanced atherosclerosis in transgenic mice overexpressing lecithin-cholesteryl acyltransferase [J].
Berard, AM ;
Foger, B ;
Remaley, A ;
Shamburek, R ;
Vaisman, BL ;
Talley, G ;
Paigen, B ;
Hoyt, RF ;
Marcovina, S ;
Brewer, HB ;
SantamarinaFojo, S .
NATURE MEDICINE, 1997, 3 (07) :744-749
[4]   APOA5 and triglyceride metabolism, lesson from human APOA5 deficiency [J].
Calandra, S ;
Oliva, CP ;
Tarugi, P ;
Bertolini, S .
CURRENT OPINION IN LIPIDOLOGY, 2006, 17 (02) :122-127
[5]   Variants at the APOA5 locus, association with carotid atherosclerosis, and modification by obesity:: the Framingham Study [J].
Elosua, Roberto ;
Ordovas, Jose M. ;
Cupples, L. Adrienne ;
Lai, Chao-Qiang ;
Demissie, Serkalem ;
Fox, Caroline S. ;
Polak, Joseph F. ;
Wolf, Philip A. ;
D'Agostino, Ralph B., Sr. ;
O'Donnell, Christopher J. .
JOURNAL OF LIPID RESEARCH, 2006, 47 (05) :990-996
[6]   Association found between the promoter region polymorphism in the apolipoprotein A-V gene and the serum triglyceride level in Japanese schoolchildren [J].
Endo, K ;
Yanagi, H ;
Araki, J ;
Hirano, C ;
Yamakawa-Kobayashi, K ;
Tomura, S .
HUMAN GENETICS, 2002, 111 (06) :570-572
[7]   Mechanism of triglyceride lowering in mice expressing human apolipoprotein A5 [J].
Fruchart-Najib, J ;
Baugé, E ;
Niculescu, LS ;
Pham, T ;
Thomas, B ;
Rommens, C ;
Majd, Z ;
Brewer, B ;
Pennacchio, LA ;
Fruchart, JC .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2004, 319 (02) :397-404
[8]   APOA5 variants and metabolic syndrome in Caucasians [J].
Grallert, Harald ;
Sedlmeier, Eva-Maria ;
Huth, Cornelia ;
Kolz, Melanie ;
Heid, Iris M. ;
Meisinger, Christa ;
Herder, Christian ;
Strassburger, Klaus ;
Gehringer, Anke ;
Haak, Markus ;
Giani, Guido ;
Kronenberg, Florian ;
Wichmann, H-Erich ;
Adamski, Jerzy ;
Paulweber, Bernhard ;
Illig, Thomas ;
Rathmann, Wolfgang .
JOURNAL OF LIPID RESEARCH, 2007, 48 (12) :2614-2621
[9]   Apolipoprotein A-V deficiency results in marked hypertriglyceridemia attributable to decreased lipolysis of triglyceride-rich lipoproteins and removal of their remnants [J].
Grosskopf, I ;
Baroukh, N ;
Lee, SJ ;
Kamari, Y ;
Harats, D ;
Rubin, EM ;
Pennacchio, LA ;
Cooper, AD .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2005, 25 (12) :2573-2579
[10]   Marked decrease of apolipoprotein A-V in both diabetic and nondiabetic patients with end-stage renal disease [J].
Hirano, Tsutomu ;
Hayashi, Toshiyuki ;
Adachi, Mitsuru ;
Taira, Takayasu ;
Hattori, Hiroaki .
METABOLISM-CLINICAL AND EXPERIMENTAL, 2007, 56 (04) :462-463